Background & Aims The Drug-Induced Liver Injury Network is conducting a prospective
study of patients with DILI in the United States. We present characteristics and subgroup …

Numerous publications contributed to the expanding knowledge base about drug-induced
liver injury (DILI) in 2015. New findings from the US Drug Induced Liver Injury Network …

Drug-induced liver injury (DILI) is an uncommon cause of acute liver injury, and there are
only a few prospective registries assessing the clinical features and outcomes of DILI …

A drug-induced liver injury (DILI) is defined as a liver injury caused by exposure to a drug or
a non-infectious toxic agent with a variable degree of organ dysfunction. A better …

Drug-induced liver injury (DILI) is increasingly being recognised as a significant cause of
both acute and chronic liver disease. The most commonly implicated agents are …

Methods: Subjects with suspected DILI due to IV medications with probable, highly likely, or
definite casuality scores were eligible. Results: Between 2004 and October 2010, 542 cases …

Drug-induced hepatotoxicity is also known as drug-induced liver injury (DILI). It is often
misdiagnosed because of its clinical and pathologic mimicry of other primary acute and …

Introduction: Drugs can induce liver injury when taken as an over-dose, or even at
therapeutic doses in susceptible individuals. Although severe drug-induced liver injury (DILI) …

Drug-induced liver injury (DILI) is common and nearly all classes of medications can cause
liver disease. Most cases of DILI are benign, and improve after drug withdrawal. It is …

Drug-induced liver injury (DILI) is an important clinical problem, which has received more
attention in recent decades. It can be induced by small chemical molecules, biological …